Yurci A., Kalkan A. O. , Ozbakir O., Karaman A. , Torun E., KULA M., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.23, ss.1206-1212, 2011 (SCI İndekslerine Giren Dergi)
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Background and aims Metabolic bone disease is common in patients with chronic liver disease. Comparative studies on the efficacies of antiosteoporotic agents in hepatic osteodystrophy have not been conducted yet. The aim of this study was to evaluate the safety and efficacy of different therapeutic regimens on hepatic osteodystrophy.